Fluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patients

Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a subset of Non-Small Cell Lung Cancers (NSCLC). We explore Fluorescence in situ Hybridization (FISH) and Immunohistochemistry (IHC) as diagnostic methods for ALK positive patients and to describe its prevalence and o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2013-01, Vol.8 (1), p.e52261-e52261
Hauptverfasser:	Martinez, Pablo, Hernández-Losa, Javier, Montero, Ma Ángeles, Cedrés, Susana, Castellví, Josep, Martinez-Marti, Alex, Tallada, Natalia, Murtra-Garrell, Nuria, Navarro-Mendivill, Alejandro, Rodriguez-Freixinos, Victor, Canela, Mercedes, Ramon y Cajal, Santiago, Felip, Enriqueta
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Adult Aged Aged, 80 and over Cancer therapies Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - enzymology Care and treatment Cellular biology Deoxyribonucleic acid Diagnostic systems DNA Epidermal growth factor Epidermal growth factor receptors Female Fluorescence Fluorescence in situ hybridization Histology Humans Hybridization Immunohistochemistry Immunohistochemistry - methods In Situ Hybridization, Fluorescence - methods Kinases Lung cancer Lung cancer, Non-small cell Lung diseases Lung Neoplasms - diagnosis Lung Neoplasms - enzymology Lymphoma Lymphomas Male Medical diagnosis Medical research Medicine Methods Middle Aged Mutation Non-small cell lung carcinoma Oncology Pathology Patients Protein-tyrosine kinase Proteins Receptor Protein-Tyrosine Kinases - metabolism Risk factors Smoking Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!